Soleno amends bylaws with advance notice changes, forum selection, governance updates

SOLENO THERAPEUTICS INC

Board approved Amended and Restated Bylaws effective March 16, 2026.
Updated advance notice provisions for stockholder proposals and director nominations.
Amendments reflect recent Delaware law changes and include a forum selection clause.
Certain governance updates and technical/clarifying changes were also made.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SOLENO THERAPEUTICS INC: Amended and Restated Bylaws to update advance notice provisions, reflect Delaware law changes, make governance updates, and include a forum selection provision (effective 2026-03-16).

Change: bylaw amendment
Effective: 2026-03-16

Exact text from the filing

On March 16, 2026, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, approved and adopted the Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), effective as of such date.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

SOLENO THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001193125-26-107429

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.